Pontifícia Universidade Católica do Paraná,, Brazil5OncoClinicas Group, Porto Alegre, RS, Brazil
Research Article
The Impact of Parkin as a Possible Future Biomarker in Five Solid Pediatric Tumors
Author(s): Castro EM, Rocha RMCM, Taques GR, Zanoni A, Percicote AP, Pereira IRPD, Poncio L, Werner B, De Souza SB, De França N, Benevides APK, De Dalke DBZ, Da Camargo CCVS, Esposito SE, Sotomaior VS, De Noronha L and Souza CM*
Pediatric neoplasms represent an important group of childhood diseases. Biomarkers with prognostic function can help to manage this complex
process. In this context, the tissue expression of parkin, could be used as a prognostic biomarker for the individual in the main solid pediatric
tumors. We aimed to investigate the correlation between the tissue expression of parkin and the clinical-pathological characteristics, and to
determine if parkin can be used as a prognostic marker. We assessed immune histochemical analysis of parkin in five solid pediatric tumors. High
tissue expression of parkin was associated with positive prognostic factors for astrocytoma’s and nephronblastomas, while in medulloblastomas
and neuroblastomas; the same underlying aspect was associated with poor prognostic factors. Choroid plexus tumors showed no association.
Parkin showed f.. Read More»
DOI:
10.37421/1747-0862.2021.15.509
Molecular and Genetic Medicine received 3919 citations as per Google Scholar report